New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
09:12 EDTADMSAdamas Pharmaceuticals initiated with an Outperform at William Blair
News For ADMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
08:34 EDTADMSAdamas Pharmaceuticals receives Orphan Drug Designation for ADS-5102
Subscribe for More Information
April 9, 2015
18:10 EDTADMSAdamas Pharmaceuticals receives FDA orphan designation for Nurelin
According to a post on the FDA's website, Adamas Pharmaceuticals' treatment of levodopa-induced dyskinesia, Nurelin, was granted orphan designation. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use